The Scientist

» clinical trials

Most Recent

image: Can Magnesium Magnify Brain Power?

Can Magnesium Magnify Brain Power?

By | October 29, 2012

A magnesium supplement thought to improve brain functioning gets a small clinical trial.

0 Comments

image: Beware of Striking Medical Studies

Beware of Striking Medical Studies

By | October 25, 2012

A large-scale statistical analysis shows that medical studies revealing “very large effects” seldom stand up when other researchers try to replicate them.

0 Comments

image: More Questions About IV Drug

More Questions About IV Drug

By | October 18, 2012

Another clinical trial raises concerns about the efficacy and safety of a common intravenous treatment for patients that have lost large amounts of blood.

0 Comments

image: Uncloaking Clinical Trials

Uncloaking Clinical Trials

By | October 17, 2012

Glaxo­SmithKline will share long-sought, raw trial data—but access will be tightly controlled.  

0 Comments

image: Cantley Changes Jobs

Cantley Changes Jobs

By | September 14, 2012

Renowned cancer researcher Lewis Cantley is leaving Harvard to lead a new cancer center at Weill Cornell Medical College and NewYork-Presbyterian Hospital.

0 Comments

image: Scientists

Scientists "Spin" Results

By | September 13, 2012

A new study of the scientific literature finds that researchers are guilty of overemphasizing the benefits of medical treatments.

0 Comments

image: Fears over Fast-Tracking Drugs

Fears over Fast-Tracking Drugs

By | September 10, 2012

Doctors question whether a government initiative to speed approval for promising new drugs is ensuring safety.

0 Comments

image: FDA to Debate Starch Treatment

FDA to Debate Starch Treatment

By | August 31, 2012

The US Food and Drug Administration will consider whether or not to stop the use of intravenous starch solutions to replace lost blood.

0 Comments

image: Epigenetic Drug Improves Cholesterol Levels

Epigenetic Drug Improves Cholesterol Levels

By | August 28, 2012

Results from a Phase II trial for cardiovascular disease with an epigenetic target therapy show promise.

1 Comment

image: Clinical Trial Misfortune

Clinical Trial Misfortune

By | August 28, 2012

A human trial of a hepatitis C treatment is shut down after one of the participants died.

1 Comment

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Culture Techniques
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
BioCision
BioCision
Advertisement
PITTCON
PITTCON
Life Technologies